President Trump praised Walmart's cheaper Thanksgiving deals as grocery giants offer holiday meal bundles under $40 for families of 10.
WMT's U.S. sales climb 4.6% in Q2 as grocery, health and e-commerce gains offset soft general merchandise trends.
Walmart (WMT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Walmart has launched several new artificial intelligence (AI) tools designed to help customers with their holiday shopping. The tools are now available on the retailer's app and website, according to a Friday (Oct. 31) press release.
WMT's digital expansion and COST's loyal membership base highlight two powerful yet distinct retail growth stories.
Eli Lilly and Walmart said they have teamed up to boost access to the pharma giant's weight loss drug Zepbound, allowing U.S. patients to access vials of the blockbuster injection at direct-to-consumer prices through retail locations for the first time. Starting in mid-November, cash-paying patients with a prescription can purchase single-dose vials of Zepbound at discounts of 50% or more through the retailer's nearly 4,600 pharmacy locations or via home delivery.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
WMT's booming ad business, up 31% at Walmart Connect, is fast emerging as a powerful profit engine beyond retail.
Eli Lilly and Walmart said on Wednesday they are partnering to expand access to single-dose vials of Lilly's weight-loss drug Zepbound, which will be offered for pick-up at Walmart pharmacies nationwide by mid-November.
Walmart announced that its teaming up with OpenAI to enable shopping directly through ChatGPT. Starting this fall, according to Bloomberg, ChatGPT users will be able to shop nearly all of Walmart's assortment, i.e.
Walmart has a new raise strategy for hourly store workers that goes beyond years of service. The new metric accounts for factors like attendance, teamwork, and store performance.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?